↓ Skip to main content

The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia

Overview of attention for article published in BMC Cancer, October 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia
Published in
BMC Cancer, October 2013
DOI 10.1186/1471-2407-13-452
Pubmed ID
Authors

Annette Künkele, Anja Grosse-Lordemann, Alexander Schramm, Angelika Eggert, Johannes H Schulte, Hagen S Bachmann

Abstract

Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer. While current treatment regimens achieve almost 80% overall survival, long-term side effects of chemotherapeutic agents can be severe. The functional BCL2-938C > A promoter polymorphism is known to influence the balance between survival and apoptosis of malignant hematolymphoid cells. We investigated its usefulness as a marker for treatment stratification for children with ALL.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 17%
Other 3 13%
Student > Ph. D. Student 3 13%
Student > Postgraduate 3 13%
Student > Master 3 13%
Other 5 21%
Unknown 3 13%
Readers by discipline Count As %
Medicine and Dentistry 10 42%
Biochemistry, Genetics and Molecular Biology 2 8%
Nursing and Health Professions 2 8%
Agricultural and Biological Sciences 2 8%
Computer Science 1 4%
Other 2 8%
Unknown 5 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2013.
All research outputs
#20,205,224
of 22,725,280 outputs
Outputs from BMC Cancer
#6,487
of 8,269 outputs
Outputs of similar age
#181,358
of 207,309 outputs
Outputs of similar age from BMC Cancer
#86
of 100 outputs
Altmetric has tracked 22,725,280 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,269 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,309 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.